EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Bhagiradha Chemicals & Industries Limited (531719) fair value: what the stock is really worth

We calculate from audited financials what Bhagiradha Chemicals & Industries Limited is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Basic Materials · IN · ISIN INE414D01019

BC Thin data Sep 13, 2026

Bhagiradha Chemicals & Industries Limited

531719 · BSE

Low PriorityFair Value upside is limited and quality is weak.

·Fair value ₹283.49 · Fairly valued (+10%)
!Quality 14/100
!Expensive Growth (revenue 5y +12.4 %/yr)
!Thin margins · 2.6% net margin (TTM)
Low debt
!Narrow moat 26/100
!Evidence only low, so the estimate is less certain
Watch Bhagiradha Chemicals & Industries Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹427.92 ₹40.79 Fair Value ₹283.49 Mar 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.

How to read this chart

60‑month range ₹40.79 – ₹427.92 · fair‑value band ₹212.62 – ₹332.25 · the ₹257.45 price screens below the ₹283.49 fair value. Dashed = 300-day average. As of Sep 13, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Bhagiradha Chemicals & Industries Limited manufactures and sells agro chemicals in India.

Show more

Bhagiradha Chemicals & Industries Limited manufactures and sells agro chemicals in India. The company offers insecticides, such as chlorpyrifos, chlorpyrifos-methyl, diafenthiuron, fipronil, buprofezin, thiamethoxam, and imidacloprid; fungicides that include azoxystrobin; herbicides, such as imazethapyr, cloquintocet-mexyl, and clodinafop-propargyl; and specialty intermediates, including hydroxyphenoxy propionic acid, dichloroaniline, and O-methylisourea hydrochloride products. It also provides contract manufacturing services. The company exports its products to the United States, Brazil, Columbia, Argentina, Mexico, Costa Rica, Germany, the United Kingdom, France, Portugal, Italy, Israel, Turkey, Iran, Indonesia, Taiwan, Malaysia, New Zealand, and Australia. Bhagiradha Chemicals & Industries Limited was founded in 1993 and is headquartered in Hyderabad, India.

Stock analysis

Bhagiradha Chemicals & Industries Limited (531719) currently trades at ₹257.45, while our model-based Fair Value estimate is ₹283.49, implying the stock looks roughly 9.2% undervalued today.

Show more

Valuation

Bull case: the Asset-Based group reads highest at a median of ₹550.07 per share, and 9 of the 16 models we run sit above the ₹257.45 price.

Bear case: the Earnings-Based group reads lowest at ₹166.09, and 7 of the 16 models stay below the price. Evidence for this calculation is low.

Scenario range: ₹212.62 (bear) to ₹332.25 (bull), the price of ₹257.45 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 14/100 (below-average quality), in the Basic Materials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Bhagiradha Chemicals & Industries Limited reported revenue of ₹4.4B in FY2025 versus ₹3.2B in FY2021, a compound +8.5%/yr. Reported net income was ₹139M in FY2025, compounding −12.2%/yr from FY2021.

Key figures

Market cap ₹3.2B (≈ $33.8M) · P/E ratio 67.9 · P/S ratio 2.14 · EPS (TTM) ₹6.37 · Dividend yield 0.4% · Net margin 3.1% · Return on equity 3.8% · Return on assets (EBIT) 11.0%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).

What moves the price

The share trades about 21% below its 52-week high and 51% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −7% fair-value upside, at 10%, 531719 screens cheaper than that median.

Fair Value models

Bear ₹212.62 Fair Value ₹283.49 Bull ₹332.25
Model Each model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 12 months old). Earnings retained since then (₹6.37 per share) are deliberately not added. Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence Evidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Residual Income ₹566.51 ₹529.51 ₹406.20 76
EPV ₹192.00 ₹227.71 ₹258.51 74
ROIC Compounder ₹192.00 ₹227.71 ₹258.51 72
All 16 models by family
Earnings-Based
Graham-Dodd ₹113.40 ₹463.40 ₹630.95 64
Lynch FV ₹116.27 ₹166.09 ₹215.92 61
PEG = 1.0 ₹116.27 ₹166.09 ₹215.92 57
EPV ₹192.00 ₹227.71 ₹258.51 74
Dividend Discount
Gordon GGM ₹13.16 ₹26.22 ₹39.70 67
DDM Multi-Stage ₹13.16 ₹22.66 ₹27.67 67
Multiples
P/E Multiple ₹212.62 ₹283.49 ₹354.37 63
P/S Multiple ₹212.62 ₹283.49 ₹354.37 58
P/B Multiple ₹212.62 ₹283.49 ₹354.37 55
EV/EBIT ₹257.58 ₹354.81 ₹452.04 66
EV/EBITDA ₹299.37 ₹410.53 ₹521.69 67
EV/Revenue ₹218.68 ₹327.03 ₹435.37 53
Asset-Based
NCAV (Graham) ₹410.50 ₹550.07 ₹820.99 54
Economic Profit
Residual Income ₹566.51 ₹529.51 ₹406.20 76
ROIC Compounder ₹192.00 ₹227.71 ₹258.51 72
Growth Earnings
Growth-Adj P/E ₹178.90 ₹255.57 ₹332.25 67

Open the full fair value analysis →

Notify me when 531719 reaches fair value

Put 531719 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 14/100

Of which business quality 19 · Market factors (momentum, volatility) 45

Profitability 24
Margins and returns on capital today
Quality Growth 29
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 48
Balance sheet, leverage, solvency risk
Investment 0
Disciplined investing over empire-building
Low Volatility 49
Calm price path (market factor)
Momentum 46
Price trend over the last 3–12 months (market factor)
52W Momentum 37
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality Growth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 49/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+8.1%
Revenue growth 3 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.4%
Revenue growth 5 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.4%
Revenue growth 11 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.8%
What shareholders gained per year (last 5 years), in INR What the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−43.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year−43.9%
Dividend (yield on the price)0.4%
Profit margin 2020 to 2025 Operating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 5%
⚠ Revenue per share shrinking 31.4%/yr over ~6Y (margins intact) Structural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.

Watch 531719, get fair value alerts →

Compare Bhagiradha Chemicals & Industries Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Agricultural Chemicals” was too small, so the broader sector is used.)Materials · 3642 stocks

Beats the sector median on 5/13 measures
Overall it trails its sector peers.
Valuation
Quality Score 14 · Bottom 25%
Fair Value upside +7% · Above median
Profitability
Return on equity (TTM) 4% · Below median
Return on assets 3% · Above median
Net margin (TTM) 3% · Below median
Operating margin (TTM) 5% · Below median
Growth and dividend
Revenue growth 35% · Top 25%
Dividend yield (TTM) 0.4% · Bottom 25%
Balance sheet
Debt / equity 0.04× · Below median

Valuation Multiplesvs Materials median · lower = cheaper

P/E (TTM) 67.9× · Priciest 25%
P/B 0.47× · Cheapest 25%
P/S (TTM) 1.55× · Pricier than median
EV/EBITDA 19.2× · Priciest 25%

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Agricultural Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Rallis India Limited 500355 ₹202.00 ₹109.39 −46%
National Fertilizers Limited 523630 ₹68.53 ₹63.75 −7%
KILPEST KILPEST ₹1,424 ₹1,566 +10%
Kilpest India Limited 532067 ₹1,424 ₹1,566 +10%
MSL MSL ₹149.00 ₹114.12 −23%
Rama Phosphates Limited 524037 ₹123.20 ₹131.39 +7%
SUCROSA SUCROSA ₹13.59 ₹4.29 −68%
Aimco Pesticides Limited 524288 ₹46.48 ₹22.31 −52%
539275 539275 ₹149.00 ₹297.19 +99%
AIMCOPEST AIMCOPEST ₹46.48 ₹37.19 −20%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Bhagiradha Chemicals & Industries Limited Fair Value". https://www.fairvalue-calculator.com/stock/531719

Frequently asked questions

Is Bhagiradha Chemicals & Industries Limited (531719) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of ₹283.49 versus a price of ₹257.45, about +10% upside (undervalued).
What is the fair value of 531719?
Our model-based fair value for Bhagiradha Chemicals & Industries Limited is ₹283.49 (as of Sep 13, 2026), built from audited fundamentals. The current price: ₹257.45.
What is the quality score of 531719?
Bhagiradha Chemicals & Industries Limited has a Quality Score of 14/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Bhagiradha Chemicals & Industries Limited (531719)?
Our model-based price target is the fair value of ₹283.49 (as of Sep 13, 2026) from 16 valuation models. Cautious scenario ₹212.62, optimistic scenario ₹332.25. It is a calculation from audited fundamentals, not an analyst target.
What is the Bhagiradha Chemicals & Industries Limited stock forecast for 2026?
Our models put fair value at ₹283.49, about +10% upside versus a price of ₹257.45 (undervalued). Cautious scenario ₹212.62, optimistic scenario ₹332.25. The calculation is refreshed regularly with new filings.
What is the revenue of Bhagiradha Chemicals & Industries Limited (531719)?
Bhagiradha Chemicals & Industries Limited reported trailing-twelve-month revenue of about ₹2.1B (latest available figure, as of Sep 13, 2026).
Does Bhagiradha Chemicals & Industries Limited pay a dividend?
Bhagiradha Chemicals & Industries Limited currently shows a dividend yield of about 0.39% relative to its recent price (as of Sep 13, 2026).
What is the intrinsic value of Bhagiradha Chemicals & Industries Limited (531719)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Bhagiradha Chemicals & Industries Limited it is ₹283.49 per share (as of Sep 13, 2026), against a price of ₹257.45. It is the blended result of 16 valuation models (cash flow, earnings, asset, dividend).
Is Bhagiradha Chemicals & Industries Limited stock overvalued or undervalued in 2026?
As of Sep 13, 2026, 531719 trades below its calculated fair value: price ₹257.45, fair value ₹283.49, a gap of about +10% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 531719?
No. The price is what the market pays today (₹257.45); the fair value is what the company's own numbers justify (₹283.49). For Bhagiradha Chemicals & Industries Limited the two are ₹26.04 per share apart. That gap is exactly why we show both numbers side by side.
How much is Bhagiradha Chemicals & Industries Limited worth?
The market values Bhagiradha Chemicals & Industries Limited at about ₹3.2B (market capitalisation, as of Sep 13, 2026). Per share that is ₹257.45; our models calculate a fair value of ₹283.49 per share.
What do the bullish and bearish scenarios say about 531719?
Our models span a range for Bhagiradha Chemicals & Industries Limited: cautious scenario ₹212.62, base ₹283.49, optimistic ₹332.25 per share (as of Sep 13, 2026, price ₹257.45). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 531719?
Bhagiradha Chemicals & Industries Limited trades at a price-to-earnings ratio of 67.9 (as of Sep 13, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹283.49 is built from several models across several years. Other multiples: P/B 0.5, P/S 1.6, EV/EBITDA 19.2.
How solid is the balance sheet of Bhagiradha Chemicals & Industries Limited (531719)?
Balance-sheet figures for Bhagiradha Chemicals & Industries Limited (as of Sep 13, 2026): return on equity 3.8%, debt of 0.04 per unit of equity. They feed the Quality Score of 14/100, which measures business quality independently of the share price.
How far is 531719 from its 52-week high?
Bhagiradha Chemicals & Industries Limited trades at ₹257.45, about 21% below its 52-week high of ₹324.23 and 51% above the low of ₹170.00 (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of ₹283.49 is for.
Which stocks are comparable to Bhagiradha Chemicals & Industries Limited?
From the same area (Basic Materials) we also value Rallis India Limited, National Fertilizers Limited, KILPEST, Kilpest India Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Bhagiradha Chemicals & Industries Limited stock attractive at the current price?
The data as of Sep 13, 2026: price ₹257.45, calculated fair value ₹283.49 (+10%), Quality Score 14/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 531719 calculated?
We run Bhagiradha Chemicals & Industries Limited through 16 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹283.49, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.8 % above its aggregate fair value. Bhagiradha Chemicals & Industries Limited currently trades 10 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What should I pay attention to with Bhagiradha Chemicals & Industries Limited right now?
Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. The price sits in the lower half of our model range, the side with the larger margin of safety. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of Bhagiradha Chemicals & Industries Limited

How large is the market capitalisation of Bhagiradha Chemicals & Industries Limited (531719)?
The market capitalisation of Bhagiradha Chemicals & Industries Limited is ₹3.2B (≈ $33.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Bhagiradha Chemicals & Industries Limited (531719)?
The price-to-sales ratio of Bhagiradha Chemicals & Industries Limited is 2.14 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Bhagiradha Chemicals & Industries Limited (531719)?
Earnings per share at Bhagiradha Chemicals & Industries Limited are ₹6.37 (price ÷ EPS = P/E 67.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Bhagiradha Chemicals & Industries Limited (531719)?
The dividend yield of Bhagiradha Chemicals & Industries Limited is 0.4% (payout 15.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Bhagiradha Chemicals & Industries Limited (531719)?
The net margin of Bhagiradha Chemicals & Industries Limited is 3.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Bhagiradha Chemicals & Industries Limited (531719)?
The return on equity (ROE) of Bhagiradha Chemicals & Industries Limited is 3.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Bhagiradha Chemicals & Industries Limited (531719)?
On an EBIT basis the return on assets of Bhagiradha Chemicals & Industries Limited is 11.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Bhagiradha Chemicals & Industries Limited (531719)?
The operating margin of Bhagiradha Chemicals & Industries Limited is 5.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Bhagiradha Chemicals & Industries Limited (531719)?
Revenue at Bhagiradha Chemicals & Industries Limited is growing +35.4% versus a year earlier (3y avg +0.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Bhagiradha Chemicals & Industries Limited (531719)?
Earnings per share at Bhagiradha Chemicals & Industries Limited are growing +164% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Watch Bhagiradha Chemicals & Industries Limited in the live analysis

One click puts Bhagiradha Chemicals & Industries Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.